Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NIO INC. (NIO)

  • SEC News
  • May 08, 2026, 11:07 UTC
  • 2
  • 0 comments

General Announcement: Record Date for Annual General Meeting of Shareholders

Comment Full text

KIORA PHARMACEUTICALS INC (KPRX)

  • SEC News
  • May 08, 2026, 11:07 UTC
  • 2
  • 1 comments

(30% Negative) KIORA PHARMACEUTICALS INC (KPRX) Reports Q2 2026 Financial Results

Comment Full text

AMERICAN REBEL HOLDINGS INC (AREB)

  • SEC News
  • May 08, 2026, 11:07 UTC
  • 2
  • 0 comments

New Form 424B2 - AMERICAN REBEL HOLDINGS INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001493152-26-021880 <b>Size:</b> 531 KB

Comment Full text

SINGAPORE TELECOMMUNICATIONS LIMITED (Z77)

  • SEC News
  • May 08, 2026, 11:06 UTC
  • 2
  • 0 comments

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Substantial Shareholders Interest in Securities

Comment Full text

HYPERLIQUID STRATEGIES INC (PURR)

  • SEC News
  • May 08, 2026, 11:06 UTC
  • 2
  • 0 comments

New Form 424B3 - Hyperliquid Strategies Inc <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-213669 <b>Size:</b> 2 MB

Comment Full text

TVARDI THERAPEUTICS, INC. (TVRD)

  • SEC News
  • May 08, 2026, 11:05 UTC
  • 2
  • 1 comments

(10% Negative) TVARDI THERAPEUTICS, INC. (TVRD) Reports Q2 2026 Financial Results

Comment Full text

1STDIBS.COM, INC. (DIBS)

  • SEC News
  • May 08, 2026, 11:05 UTC
  • 2
  • 1 comments

(30% Negative) 1STDIBS.COM, INC. (DIBS) Reports Q2 2026 Financial Results

Comment Full text

BOUNDLESS BIO, INC. (BOLD)

  • SEC News
  • May 08, 2026, 11:05 UTC
  • 2
  • 1 comments

(10% Negative) BOUNDLESS BIO, INC. (BOLD) Reports Q2 2026 Financial Results

Comment Full text

TREACE MEDICAL CONCEPTS, INC. (TMCI)

  • SEC News
  • May 08, 2026, 11:05 UTC
  • 2
  • 1 comments

(30% Negative) TREACE MEDICAL CONCEPTS, INC. (TMCI) Reports Q2 2026 Financial Results

Comment Full text

LENSAR, INC. (LNSR)

  • SEC News
  • May 08, 2026, 11:05 UTC
  • 2
  • 1 comments

(30% Negative) LENSAR, INC. (LNSR) Reports Q2 2026 Financial Results

Comment Full text
  • Previous
  • 196
  • 197
  • 198
  • 199
  • 200
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158461)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin